Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up

Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Mats Fredrikson, Per Stål, Stergios Kechagias, Rolf Hultcrantz – 14 August 2014 – Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the Western world, strongly associated with insulin resistance and the metabolic syndrome. Nonalcoholic steatohepatitis, i.e., fatty liver accompanied by necroinflammatory changes, is mostly defined by the NAFLD activity score (NAS).

Circulating MicroRNAs as a marker for liver injury in human immunodeficiency virus patients

Evrim Anadol, Robert Schierwagen, Natalia Elfimova, Katharina Tack, Carolynne Schwarze‐Zander, Hanna Eischeid, Andrea Noetel, Christoph Boesecke, Christian Jansen, Leona Dold, Jan‐Christian Wasmuth, Christian P. Strassburg, Ulrich Spengler, Jürgen Kurt Rockstroh, Margarete Odenthal, Jonel Trebicka – 14 August 2014 – Human immunodeficiency virus (HIV) and hepatitis virus coinfection amplify and accelerate hepatic injury. MicroRNAs (miRNAs) are small regulatory RNAs suggested as biomarkers for liver injury.

Diaphragmatic hernia after liver transplantation in children: Case series and review of the literature

Miriam Cortes, Niteen Tapuria, Shirin Elizabeth Khorsandi, Eugenia Pareja Ibars, Hector Vilca‐Melendez, Mohamed Rela, Nigel D. Heaton – 13 August 2014 – A diaphragmatic hernia (DH) is a rare complication of pediatric liver transplantation (LT), with multiple factors implicated in the pathophysiology. It is a potentially life‐threatening condition in the absence of early recognition and surgical treatment. A DH after LT has been reported in 16 patients in 7 case series. We report 10 cases from our institution and review the published literature to understand the underlying pathophysiology.

Late diagnosis of hepatitis C virus infection in the Chronic Hepatitis Cohort Study (CHeCS): Missed opportunities for intervention

Anne C. Moorman, Jian Xing, Stephen Ko, Loralee B. Rupp, Fujie Xu, Stuart C. Gordon, Mei Lu, Philip R. Spradling, Eyasu H. Teshale, Joseph A. Boscarino, Vinutha Vijayadeva, Mark A. Schmidt, Scott D. Holmberg, for the CHeCS Investigators – 13 August 2014 – To determine the stage of liver disease at initial diagnosis of hepatitis C virus (HCV) infection, we analyzed data from the Chronic Hepatitis Cohort Study (CHeCS), a large U.S. observational study.

Subscribe to